OG
Organon & Co.
OGN · NYSE
$13.75 -0.22% (-$0.03)
1M +0.95%
Market Cap $3.61B
P/E Ratio 17.28x
Div. Yield 0.58%
ROE 23.44%
Bulios Fair Price
$8.02
41.7% downside
Trenutna cena
$13.75
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica OGN trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
6/9Valuation
85 /100
Cheap P/E 17.28x
P/FCF 7.25x
EV/EBITDA 8.45x
Growth
23 /100
Declining EPS growth 41.47%
FCF growth 7.67%
Rev. growth 0.23%
Profitability
66 /100
Moderate Gross margin 52.98%
FCF margin 8.13%
Net margin 3.41%
Quality
48 /100
Average ROIC 4.73%
Asset turnover 0.46x
ROE 23.44%
Debt
20 /100
High Debt/Equity 8.50x
Net debt/EBITDA 5.68x
Current ratio 1.95x
Stability
66 /100
Moderate Beta 1.52x
Profitable years 6
Rev. volatility 2.78%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o OGN
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Joseph T. Morrissey Jr.
Employees
10,000
Headquarters
Jersey City
Prihajajoči dogodki
09 NOV.
Earnings
Upcoming earnings report